Provided by Tiger Trade Technology Pte. Ltd.

Immix Biopharma, Inc.

10.00
-0.1100-1.09%
Post-market: 10.000.00000.00%18:03 EDT
Volume:607.70K
Turnover:6.08M
Market Cap:529.55M
PE:-12.86
High:10.39
Open:10.20
Low:9.78
Close:10.11
52wk High:10.71
52wk Low:1.34
Shares:52.96M
Float Shares:41.44M
Volume Ratio:0.71
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.7641
ROE:-182.55%
ROA:-66.48%
PB:64.07
PE(LYR):-13.09

Loading ...

Jan 18, 2023

Major Issues Report

8-K - Current report
Jan 09, 2023

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 14, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 09, 2022

Major Issues Report

8-K - Current report
May 27, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 27, 2022

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 12, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Major Issues Report

8-K - Current report